American Society of Hematology

Figure 5.

$Figure 5. CECs at baseline and after 2 months of therapy in patients with PD, SD, PR, or CR. Top panel shows absolute CEC counts; bottom panel shows how the fraction of apoptotic CECs contributed to the absolute CEC count in patients with or without clinical benefit. Results are expressed as mean ± SD.$

CECs at baseline and after 2 months of therapy in patients with PD, SD, PR, or CR. Top panel shows absolute CEC counts; bottom panel shows how the fraction of apoptotic CECs contributed to the absolute CEC count in patients with or without clinical benefit. Results are expressed as mean ± SD.

This Feature Is Available To Subscribers Only